Why the NIB (ASX:NHF) share price is one of the best performers on the ASX 200 today

It has been a great day for NIB shareholders…

| More on:
a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price has been among the best performers on the ASX 200 on Thursday.

In afternoon trade, the private health insurer's shares are up 4.5% to $7.05.

This latest gain means the NIB share price is now up almost 17% in 2021.

Why is the NIB share price charging higher today?

The catalyst for the rise in the NIB share price today has been the release of a trading update at its annual general meeting. That update reveals that NIB has started FY 2022 in a very positive fashion.

According to the release, the private health insurer's premium revenue increased 8.5% over the prior corresponding period to $669.5 million during the first quarter. This was driven by modest increases in policyholder numbers in Australia and New Zealand and premium increases.

In respect to the former, Australian resident health insurance (ARHI) policyholders increased 0.6% and New Zealand policyholders grew 1.3%. Offsetting this slightly was a 0.1% decline in international inbound health insurance (IIHI) policyholders.

Also potentially giving the NIB share price a boost was its claims update. The release shows that estimated ARHI claims fell 2.4% over the prior corresponding period to $442.5 million.

What's next?

There was no mention of its guidance at the meeting. In light of this, the company appears to still be targeting ARHI net policyholder growth in the range of 2% to 3%.

At the meeting, NIB's new Chair, Steve Crane, spoke positively about the future.

He said: "While FY21 has certainly been another extra-ordinary year and not without its challenges, our business is in very good shape. We continue to grow with increased profitability, we are well capitalised and there is no shortage of opportunity ahead."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »